Topaicí molta laistigh de do chuardach.
Topaicí molta laistigh de do chuardach.
- COVID-19 38
- Coronavirus infections
- SARS-CoV-2 38
- COVID-19 (Disease) 36
- Coronavirus Infections 24
- Research 22
- Betacoronavirus 20
- immunology 19
- Development 17
- Vaccination 14
- COVID-19 Vaccines 13
- prevention & control 13
- Vaccines 12
- virology 11
- Coronaviruses 10
- Immunological aspects 10
- Pandemics 10
- Pneumonia, Viral 10
- Treatment 10
- drug therapy 10
- Drug Development 9
- Antiviral agents 8
- administration & dosage 8
- drug effects 8
- Antiviral Agents 7
- Clinical trials 7
- Communicable Diseases, Emerging 7
- therapeutic use 7
- COVID-19 Pandemic, 2020- 6
- Chemotherapy 6
-
1
SARS-CoV-2 monoclonal antibody testing in vivo
Foilsithe / Cruthaithe 2021Faigh an téacs iomlán
Series
Leictreonach Fuaim -
2
mRNA COVID-19 vaccine efficacy in recovered vs COVID-naive individuals
Foilsithe / Cruthaithe 2021Faigh an téacs iomlán
Series
Leictreonach Fuaim -
3
SARS-COV-2 human monoclonal antibody therapy update
Foilsithe / Cruthaithe 2021Faigh an téacs iomlán
Series
Leictreonach Fuaim -
4
SARS-CoV-2 evolution within and between individuals
Foilsithe / Cruthaithe 2021Faigh an téacs iomlán
Series
Leictreonach Fuaim -
5
Genetic surveillance and the emergence of SARS-CoV-2 variants
Foilsithe / Cruthaithe 2021Faigh an téacs iomlán
Series
Leictreonach Fuaim -
6
Comparison of COVID-19 and seasonal HCoV pathologies and transfer to endemic state
Foilsithe / Cruthaithe 2021Faigh an téacs iomlán
Series
Leictreonach Fuaim -
7
The role of Neuropilin-1 as a SARS-CoV-2-specific endocytosis potentiator
Foilsithe / Cruthaithe 2021Faigh an téacs iomlán
Series
Leictreonach Fuaim -
8
SARS-CoV-2 vaccine rollout campaigns
Foilsithe / Cruthaithe 2021Faigh an téacs iomlán
Series
Leictreonach Fuaim -
9
Update on the SNG001 drug, an INFbeta therapy for COVID-19
Foilsithe / Cruthaithe 2020Faigh an téacs iomlán
Series
Leictreonach Fuaim -
10
The neurological symptoms of COVID-19
Foilsithe / Cruthaithe 2020Faigh an téacs iomlán
Series
Leictreonach Fuaim -
11
Imperial College London's saRNA Vaccine - COVAC1
Foilsithe / Cruthaithe 2020Faigh an téacs iomlán
Series
Leictreonach Fuaim -
12
Potential long-term health effects of a SARS-CoV-2 infection
Foilsithe / Cruthaithe 2020Faigh an téacs iomlán
Series
Leictreonach Fuaim -
13
Interferon-α2b as a therapy for COVID-19
Foilsithe / Cruthaithe 2020Faigh an téacs iomlán
Series
Leictreonach Fuaim -
14
Presence and function of SARS-CoV-2-specific T-cells in recovered patients and healthy volunteers
Foilsithe / Cruthaithe 2020Faigh an téacs iomlán
Series
Leictreonach Fuaim -
15
Rheumatic diseases and COVID-19
Foilsithe / Cruthaithe 2020Faigh an téacs iomlán
Series
Leictreonach Fuaim -
16
The cardiovascular complications of SARS-CoV-2 infection
Foilsithe / Cruthaithe 2020Faigh an téacs iomlán
Series
Leictreonach Fuaim -
17
Approaches for elucidating genetic susceptibility to SARS-CoV-2
Foilsithe / Cruthaithe 2020Faigh an téacs iomlán
Series
Leictreonach Fuaim -
18
The immune system response to the SARS-CoV-2 virus July 2020 update /
Foilsithe / Cruthaithe 2020Faigh an téacs iomlán
Series
Leictreonach Fuaim -
19
The development of SARS-CoV-2 vaccines
Foilsithe / Cruthaithe 2020Faigh an téacs iomlán
Series
Leictreonach Fuaim -
20
Convalescent plasma therapy as a treatment for COVID-19
Foilsithe / Cruthaithe 2020Faigh an téacs iomlán
Series
Leictreonach Fuaim